Scientific partners Asthma Prevention

Scientists Asthma Prevention

These scientists are involved in the Asthma Prevention Consortium. 

Partner

Bart Lambrecht, MD PhD

Professor at Universiteit Gent / VIB

Partner

Benjamin Marsland, PhD

Professor at Monash University

Partner

Christian Taube, MD PhD

Professor at Universitätsklinikum Essen

Partner

Erika von Mutius, MD PhD

Professor at Ludwig-Maximilians-Universität München

Partner

Hamida Hammad, PhD

Professor at Universiteit Gent / VIB

Partner

Henry McSorley, PhD

University of Edinburgh

Partner

Hermelijn Smits, PhD

Leids Universitair Medisch Centrum

Partner

Markus Ege, MD PhD

Professor at Ludwig-Maximilians-Universität München

Partner

Pieter Hiemstra, PhD

Professor at Leids Universitair Medisch Centrum

Partner

Rick Maizels, PhD

Professor at University of Glasgow

Translational Committee Asthma Prevention Consortium

The Translational Committee for the Asthma Prevention Consortium was formed with the aim to steer the scientific strategy and expedite the translation of scientific discovery into meaningful health outcomes. Members of the Committee:

  • Jeffrey Drazen, MD
    Editor-in-Chief of the New England Journal of Medicine
    Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School
  • Paul Peter Tak, PhD, MD
    CEO Kintai Therapeutics
    Professor of Medicine, University of Amsterdam
  • Anne Leendertse, PhD
    Clinical Pharmacist 
    Patient representative
  • René Raggers, PhD
    Senior European and Dutch Patent Attorney
  • Hans Bisgaard, MD, DMSc
    Professor of Pediatrics
    Copenhagen Prospective Studies on Asthma in Childhood (COPSAC)

FLTR Paul Peter Tak, Iman Schultz (Longfonds), Jeffrey Drazen, René Raggers, Anne Leendertse, Hans Bisgaard

Patient Advisory Committee Asthma Prevention Consortium

To emphasize the Lung Foundation Netherlands’ commitment to its patient interest agenda, a Patient Advisory Committee (PAC) is actively involved in the Asthma Prevention Consortium. The participation of patient representatives affords the consortium direct insight into the issues and challenges faced by lung patients, esp. asthma. The PAC is responsible for identifying and prioritizing topics to be addressed by the consortium from the patient perspective. Their involvement improves outcomes for lung patients and ensures successful implementation of future products. Members of the Committee (as of April 2019):

  • Bianca Bosman, the Netherlands
  • Jesca Groenendijk, the Netherlands
  • Anne Leendertse, the Netherlands
  • Martine Puhl, the Netherlands
  • Amanda Roberts, United Kingdom

FLTR Anne Leendertse, Martine Puhl, Jesca Groenendijk and Amanda Roberts.